Salarius Pharmaceuticals, INC. (DCOY) SEC Filings — 2024
23 SEC filings for Salarius Pharmaceuticals, INC. (DCOY) in 2024.
Filings
- Salarius Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Dec 23, 2024
- Salarius Pharmaceuticals Files S-1 for Potential Securities Offering — S-1 · Dec 16, 2024
- Salarius Pharmaceuticals Files 8-K with Material Agreement — 8-K · Dec 13, 2024
- Salarius Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Salarius Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Salarius Pharmaceuticals Files Proxy Materials — DEFA14A · Nov 1, 2024
- Salarius Pharmaceuticals Files 8-K on Shareholder Nominations — 8-K · Sep 27, 2024
- Salarius Pharmaceuticals Raises $1M in Direct Offering — 8-K · Aug 15, 2024
- Salarius Pharmaceuticals to be Acquired by Evren Technologies — 8-K · Aug 14, 2024
- Salarius Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 9, 2024
- Salarius Pharmaceuticals Files 8-K — 8-K · Jul 25, 2024
- Salarius Pharmaceuticals to be Acquired by Big Rock Partners — 8-K · Jul 23, 2024
- Salarius Pharmaceuticals to be Acquired by Evrensel Group — 8-K · Jul 19, 2024
- Salarius Pharmaceuticals to be Acquired by Evren Technologies — 8-K · Jul 11, 2024
- Salarius Pharmaceuticals Files 8-K — 8-K · Jun 17, 2024
- Salarius Pharmaceuticals Files 8-K Report — 8-K · Jun 14, 2024
- Salarius Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Salarius Pharmaceuticals Files 10-K/A Amendment — 10-K/A · Apr 22, 2024
- Salarius Pharmaceuticals Announces Special Meeting for Reverse Stock Split — DEF 14A · Mar 26, 2024
- Salarius Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 22, 2024
- Salarius Pharmaceuticals Faces Delisting Notice — 8-K · Mar 6, 2024
- Salarius Pharmaceuticals Files 8-K on Officer Changes and Other Events — 8-K · Feb 23, 2024
- Salarius Pharmaceuticals, INC. SC 13G Filing — SC 13G · Feb 14, 2024